ClinicalTrials.Veeva

Menu

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

A

Asociación para Evitar la Ceguera en México

Status and phase

Withdrawn
Phase 3

Conditions

Diabetic Retinopathy

Treatments

Procedure: Vitrectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT00407108
APEC-005

Details and patient eligibility

About

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Advanced diabetic retinopathy with retinal detachment

Exclusion criteria

  • Retinal detachments of more than 6 months

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Hugo Quiroz-Mercado, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems